Skip to content
Sign up today for access to the latest pediatric solutions!
Sign up today for access to the latest pediatric solutions!

IP License - Dermatophytosis Prophylaxis and Treatment

IP Licensing
Availability: Available On Demand

For informational purposes only. Please contact seller directly for more details.

Share This:

Children’s Mercy Kansas City has developed a composition and method for the prophylaxis and treatment of topical fungal infections of the hair and skin. Tinea capitis, a fungal infection of the scalp, has become widely integrated into metropolitan communities. Symptoms generally present as single or multiple patches of hair loss accompanied by inflammation, scaling, pustules and itching. Current oral treatments have challenges such as compliance issues, liver toxicity and/or interactions with other drugs. Importantly long-term follow-up of the children in our studies demonstrate that efficacy rates for existing oral anti-fungals is unacceptably low.

This innovation, a stain composition, is applicable for products for topical application for prevention and treatment of tinea capitis as well as products to be applied to fomites such as bed sheets, hairbrushes or things that carry the fungus and provide a means of re-infection. If interested in licensing and/or research collaborations, contact Children’s Mercy Kansas City to have discussions. US Patent issued.

Shipping Information

Digital delivery/downloads will typically be delivered within 2 business days.

Physical products typically take 5-8 business days. Please contact the seller directly with any questions about your order.

You will receive an order confirmation email from PedsMrkt followed by a shipping email when your order ships.

Returns

Please contact the seller directly for their return policy and to
handle returns. Customer will be responsible for return shipping fees.